Ruff Shamim
Director at REATA PHARMACEUTICALS INC; SVP, Regulatory Affairs & Qual at SRPT
- Sold, on record
- $3.9M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Jul 28, 2023
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- REATA PHARMACEUTICALS INCDirector
- SRPTSarepta Therapeutics, Inc.SVP, Regulatory Affairs & Qual
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- SRPT39,449 shares
- REATA PHARMACEUTICALS INC13,975 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale SRPTUnusualSep 22, 2016 2016
Sold 7,311 shares at $60.00 ($439k)
Ruff Shamim, SVP, Regulatory Affairs & Qual
Sold 26.5% of holdings ($1.7M position)20,239 shares leftFirst sale on recordFiling
- 2 Form 4 sale SRPTUnusualJul 21, 2017 +302 days
Sold 10,638 shares at $42.82 ($456k)
Ruff Shamim, SVP, Regulatory Affairs & Qual
Sold 33.6% of holdings ($1.4M position)21,062 shares leftFiling
- 3 Form 4 sale SRPTUnusualOct 3, 2017 +74 days
Sold 11,500 shares at $50.00 ($575k)
Ruff Shamim, SVP, Regulatory Affairs & Qual
Sold 29.8% of holdings ($1.9M position)27,045 shares leftFiling
- 4 Form 4 sale SRPTUnusualNov 6, 2017 +34 days
Sold 10,000 shares at $55.00 ($550k)
Ruff Shamim, SVP, Regulatory Affairs & Qual
Sold 27% of holdings ($2M position)27,045 shares left0.9x usual sizeFiling
- 5 Form 4 sale REATA PHARMACEUTICALS INCUnusualMar 10, 2023 +1950 days
Sold 5,740 shares at $83.73 ($481k)
Ruff Shamim, Director
Sold 52.4% of holdings ($918k position)5,223 shares leftFirst sale on recordFiling
- 6 Form 144 notice REATA PHARMACEUTICALS INCNoticeJul 28, 2023 +140 days
Filed to sell 8,235 shares ($1.4M)
Ruff Shamim, Director
10b5-1 planFiling
- 7 Form 4 sale REATA PHARMACEUTICALS INCRoutineJul 28, 2023 same day
Sold 8,235 shares at $164.53 ($1.4M)
Ruff Shamim, Director
10b5-1 planSold 52.8% of holdings ($2.6M position)7,359 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 28, 2023 | Aug 1, 2023 | REATA PHARMACEUTICALS INC | Director | Form 4 sale | 8,235 | $1.4M | 52.8% | Routine | SEC |
| Jul 28, 2023 | Jul 28, 2023 | REATA PHARMACEUTICALS INC | Director | Form 144 notice | 8,235 | $1.4M | Notice | SEC | |
| Mar 10, 2023 | Mar 13, 2023 | REATA PHARMACEUTICALS INC | Director | Form 4 sale | 5,740 | $481k | 52.4% | Unusual | SEC |
| Nov 6, 2017 | Nov 8, 2017 | SRPT | SVP, Regulatory Affairs & Qual | Form 4 sale | 10,000 | $550k | 27.0% | Unusual | SEC |
| Oct 3, 2017 | Oct 5, 2017 | SRPT | SVP, Regulatory Affairs & Qual | Form 4 sale | 11,500 | $575k | 29.8% | Unusual | SEC |
| Jul 21, 2017 | Jul 21, 2017 | SRPT | SVP, Regulatory Affairs & Qual | Form 4 sale | 10,638 | $456k | 33.6% | Unusual | SEC |
| Sep 22, 2016 | Sep 30, 2016 | SRPT | SVP, Regulatory Affairs & Qual | Form 4 sale | 7,311 | $439k | 26.5% | Unusual | SEC |